Product Information
BANZEL 200 MG TABLET is a brand product labeled by Eisai Inc., priced at $12.6024 per EA under NDC 62856058252. Its NADAC has been published 623 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the rufinamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Eisai Inc.NDC
62856058252
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021911On Market Since
11/14/2008
Price Statistics
The NADAC for BANZEL 200 MG TABLET has been published 623 times since Nov 28, 2013, and over the history we have for it it has risen 154.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.6024 per EA |
|---|---|
| All-time high | $12.6907 (Nov 16, 2022) |
| All-time low | $4.9463 (Nov 28, 2013) |
| 52-week high | $12.6164 |
| 52-week low | $12.5976 |
| Median price | $11.4990 |
| Average price | $10.5657 |
| Largest weekly change | +9.9% (Feb 4, 2015) |
| Weeks tracked | 623 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BANZEL 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BANZEL 200 MG TABLET, manufactured by Eisai Inc., is $12.6024 per EA (NDC 62856058252), effective Jun 24, 2026.
How has the price of BANZEL 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for BANZEL 200 MG TABLET has risen 154.8%. It has been tracked across 623 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BANZEL 200 MG TABLET?
Since Nov 28, 2013, the NADAC for BANZEL 200 MG TABLET has ranged from a low of $4.9463 (Nov 28, 2013) to a high of $12.6907 (Nov 16, 2022), with a median of $11.4990 per EA.
Are there cheaper alternatives to BANZEL 200 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RUFINAMIDE 200 MG TABLET, is $0.8636 per EA — about 93% below BANZEL 200 MG TABLET.
Who manufactures BANZEL 200 MG TABLET?
BANZEL 200 MG TABLET (NDC 62856058252) is labeled by Eisai Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification